Fig. 3From: FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinomaOverall survival curve of total 101 patients stratified by two cutoff points, max SUVmax 7.0 and 12.0Back to article page